FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200577784> ?p ?o ?g. }

• W4200577784 endingPage "100882" @default.
• W4200577784 startingPage "100882" @default.
• W4200577784 abstract "B-cell non-Hodgkin lymphomas (NHLs) are significant contributors to cancer-related mortality. In this single-arm, retrospective cohort study, we aimed to examine the outcomes of a radioimmunotherapeutic modality, 90Y-labeled ibritumomab tiuxetan (90YIT) in B-cell NHLs.We conducted this study based on data from the United Arab Emirates lymphoma registry. All patients with NHL subjected to 90YIT were eligible for inclusion. The country of research lacked a national autologous stem cell transplantation (ASCT) center, but many ASCT-eligible patients received 90YIT. We investigated overall survival (OS) and event-free survival (EFS), as well as safety outcomes.Between 2004 and 2008, 54 of 111 patients with B-cell NHL received radioimmunotherapy. The therapy was applied as first-line treatment in 18 cases (33.3%) and second- or later-line treatment in 36 cases (66.7%). All patients were evaluable for response. The first-line group consisted mainly of follicular lymphoma cases, and 3 of 18 patients died (16.7%) during the follow-up (range, 22-67 months). Median OS was not reached. No progression occurred after treatment (median EFS, 36.5 months [Q1-Q3 range, 30.5-44 months]). The second- or later-line group consisted mainly of diffuse large B-cell lymphoma cases, and 3 of 36 patients died (8.3%) during the follow-up (range, 4-68 months). Median OS was not reached. One case of progression was registered (median EFS: 33 months [Q1-Q3 range, 30.5-44 months]). 90YIT had acceptable short- and long-term safety profiles.The findings suggest that patients with NHL may benefit from 90YIT as salvage treatment if ASCT is not available; however, this should be validated in randomized studies." @default.
• W4200577784 created "2021-12-31" @default.
• W4200577784 creator A5003252508 @default.
• W4200577784 creator A5009065083 @default.
• W4200577784 creator A5009607405 @default.
• W4200577784 creator A5011208183 @default.
• W4200577784 creator A5015423064 @default.
• W4200577784 creator A5021022336 @default.
• W4200577784 creator A5063856017 @default.
• W4200577784 creator A5071599227 @default.
• W4200577784 date "2022-09-01" @default.
• W4200577784 modified "2023-10-16" @default.
• W4200577784 title "90Y-ibritumomab Tiuxetan in B-cell Non-Hodgkin Lymphomas: Real-world Data From the United Arab Emirates" @default.
• W4200577784 cites W1858444101 @default.
• W4200577784 cites W1912693401 @default.
• W4200577784 cites W2038410876 @default.
• W4200577784 cites W2044460265 @default.
• W4200577784 cites W2045209749 @default.
• W4200577784 cites W2050115670 @default.
• W4200577784 cites W2051058786 @default.
• W4200577784 cites W2059168512 @default.
• W4200577784 cites W2060064772 @default.
• W4200577784 cites W2080742973 @default.
• W4200577784 cites W2094244161 @default.
• W4200577784 cites W2106294189 @default.
• W4200577784 cites W2110646221 @default.
• W4200577784 cites W2115968060 @default.
• W4200577784 cites W2124432094 @default.
• W4200577784 cites W2127249281 @default.
• W4200577784 cites W2132443196 @default.
• W4200577784 cites W2133201432 @default.
• W4200577784 cites W2136060045 @default.
• W4200577784 cites W2144367322 @default.
• W4200577784 cites W2155009647 @default.
• W4200577784 cites W2157591656 @default.
• W4200577784 cites W2164532418 @default.
• W4200577784 cites W2277880221 @default.
• W4200577784 cites W2310716991 @default.
• W4200577784 cites W2387722612 @default.
• W4200577784 cites W2587304912 @default.
• W4200577784 cites W2756143810 @default.
• W4200577784 cites W2806125404 @default.
• W4200577784 cites W2902275389 @default.
• W4200577784 cites W2999740565 @default.
• W4200577784 cites W4236717099 @default.
• W4200577784 cites W4248583329 @default.
• W4200577784 cites W4255164806 @default.
• W4200577784 doi "https://doi.org/10.1016/j.adro.2021.100882" @default.
• W4200577784 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36148378" @default.
• W4200577784 hasPublicationYear "2022" @default.
• W4200577784 type Work @default.
• W4200577784 citedByCount "0" @default.
• W4200577784 crossrefType "journal-article" @default.
• W4200577784 hasAuthorship W4200577784A5003252508 @default.
• W4200577784 hasAuthorship W4200577784A5009065083 @default.
• W4200577784 hasAuthorship W4200577784A5009607405 @default.
• W4200577784 hasAuthorship W4200577784A5011208183 @default.
• W4200577784 hasAuthorship W4200577784A5015423064 @default.
• W4200577784 hasAuthorship W4200577784A5021022336 @default.
• W4200577784 hasAuthorship W4200577784A5063856017 @default.
• W4200577784 hasAuthorship W4200577784A5071599227 @default.
• W4200577784 hasBestOaLocation W42005777841 @default.
• W4200577784 hasConcept C126322002 @default.
• W4200577784 hasConcept C141071460 @default.
• W4200577784 hasConcept C143998085 @default.
• W4200577784 hasConcept C159654299 @default.
• W4200577784 hasConcept C203014093 @default.
• W4200577784 hasConcept C2776146153 @default.
• W4200577784 hasConcept C2777058707 @default.
• W4200577784 hasConcept C2778476748 @default.
• W4200577784 hasConcept C2778515704 @default.
• W4200577784 hasConcept C2779050716 @default.
• W4200577784 hasConcept C2779338263 @default.
• W4200577784 hasConcept C2780653079 @default.
• W4200577784 hasConcept C542903549 @default.
• W4200577784 hasConcept C71924100 @default.
• W4200577784 hasConceptScore W4200577784C126322002 @default.
• W4200577784 hasConceptScore W4200577784C141071460 @default.
• W4200577784 hasConceptScore W4200577784C143998085 @default.
• W4200577784 hasConceptScore W4200577784C159654299 @default.
• W4200577784 hasConceptScore W4200577784C203014093 @default.
• W4200577784 hasConceptScore W4200577784C2776146153 @default.
• W4200577784 hasConceptScore W4200577784C2777058707 @default.
• W4200577784 hasConceptScore W4200577784C2778476748 @default.
• W4200577784 hasConceptScore W4200577784C2778515704 @default.
• W4200577784 hasConceptScore W4200577784C2779050716 @default.
• W4200577784 hasConceptScore W4200577784C2779338263 @default.
• W4200577784 hasConceptScore W4200577784C2780653079 @default.
• W4200577784 hasConceptScore W4200577784C542903549 @default.
• W4200577784 hasConceptScore W4200577784C71924100 @default.
• W4200577784 hasIssue "5" @default.
• W4200577784 hasLocation W42005777841 @default.
• W4200577784 hasLocation W42005777842 @default.
• W4200577784 hasLocation W42005777843 @default.
• W4200577784 hasLocation W42005777844 @default.
• W4200577784 hasOpenAccess W4200577784 @default.
• W4200577784 hasPrimaryLocation W42005777841 @default.
• W4200577784 hasRelatedWork W2005708883 @default.

• next